Showing results (271-280 of 320) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|June 2, 2018
lH-Pyrazolo[3,4-b]quinolin-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrestChandrabose Karthikeyan, Haneen Amawi, Arabela Guedes Viana, et al.
Cancer Biology & Medicine|September 30, 2025
Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancerHaneen Amawi, Alaa M Hammad, F Scott Hall, et al.
Genes, Brain, and Behavior|September 11, 2025
Dapagliflozin Reverses LPS-Induced Depressive-Like Behavior in Mice via Modulation of Glutamate and NF-κBHaneen Amawi, Sahar Alsheyab, Alaa M Hammad, et al.
Molecules (Basel, Switzerland)|July 9, 2020
Novel Chrysin-De-Allyl PAC-1 Hybrid Analogues as Anticancer Compounds: Design, Synthesis, and Biological EvaluationButhina A Al-Oudat, Hariteja Ramapuram, Saloni Malla, et al.
Neuropharmacology|January 13, 2009
The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in ratsXiao-Qing Peng, Charles R Ashby, Krista Spiller, et al.
Plos One|October 21, 2009
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10)Tong Shen, Ye-Hong Kuang, Charles R Ashby, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 5, 2023
Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkersJuan Jin, Yuhao Xie, Jin-Shi Zhang, et al.
Journal of Continuing Education in Nursing|August 3, 2010
Showcasing differences between quality improvement, evidence-based practice, and researchMaria R Shirey, Sheila L Hauck, Jennifer L Embree, et al.
European Journal of Pharmacology|March 10, 2001
GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamineM R Gerasimov, W K Schiffer, E L Gardner, et al.
Frontiers in Oncology|July 18, 2020
Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer CellsYi-Dong Li, Yong Mao, Xing-Duo Dong, et al.
Pageof 32